Coley's toxins, tumor necrosis factor and cancer research: A historical perspective

As far back of the 1700s, it was recorded that certain infectious disease processes could be exert beneficial therapeutic effect upon malignancy. Most prominent among the numerous deliberate efforts made to take advantage of these observations was that of a pioneering New York surgeon, William B. Co...

Full description

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 64; no. 3; pp. 529 - 564
Main Authors Wiemann, Bernadette, Starnes, Charlie O.
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 1994
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:As far back of the 1700s, it was recorded that certain infectious disease processes could be exert beneficial therapeutic effect upon malignancy. Most prominent among the numerous deliberate efforts made to take advantage of these observations was that of a pioneering New York surgeon, William B. Coley, active career 1891–1936. Using a bacterial vaccine to treat primarily inoperable sarcoma, Coley accomplished a cure rate of better than 10%. This review examines the history of these efforts and presents a discussion of their corresponding relevance to present day immunotherapy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ObjectType-Biography-4
ISSN:0163-7258
1879-016X
DOI:10.1016/0163-7258(94)90023-X